HAHHHAHAHAHAA THE 2 NEW $ABVX CASES WERE PRE-EXISTING!
-"Myoproliferative neoplasm" patient entered the study with platelet count >900K (i.e. HE ALREADY HAD THE MALIGNANCY)
-Prostate cancer was exposed to obefazimod for ONLY 3 MONTHS BEFORE HE WAS DIAGNOSED!!! Zero chance that this was a de novo prostate case (famously one of the slowest growing cancers, taking YEARS to be diagnosed after it developes).
This cancer scare thing is now fully, officially, OVER. DONE!
Clean label + best ever efficacy.
Re-Rate this damn thing!!!